Detalhe da pesquisa
1.
Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.
Clin Trials
; 10(1 Suppl): S5-S36, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-22547421